| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |